Tracing of intracellular pH in cancer cells in response to Taxol treatment

References

• Weaver BA, Bement W. How Taxol/paclitaxel kills cancer cells. Mol Biol Cell. 2014;25(18):2677–2681.
   PubMed Web of Science ®Google Scholar
• Barbuti AM, Chen ZS. Paclitaxel through the ages of anticancer therapy: exploring its role in chemoresistance and radiation therapy. Cancers (Basel). 2015;7(4):2360–2371.
   PubMed Web of Science ®Google Scholar
• Horwitz SB. Taxol (paclitaxel): mechanisms of action. Ann Oncol. 1994;5(Suppl 6):S3–6.
   PubMedGoogle Scholar
• Blagosklonny MV, Giannakakou P, El-deiry WS, et al. Raf-1/bcl-2 phosphorylation: a step from microtubule damage to cell death. Cancer Res. 1997;57(1):130–135.
   PubMed Web of Science ®Google Scholar
• Ling YH, Yang Y, Tornos C, et al. Paclitaxel-induced apoptosis is associated with expression and activation of c-Mos gene product in human ovarian carcinoma SKOV3 cells. Cancer Res. 1998;58(16):3633–3640.
   PubMed Web of Science ®Google Scholar
• Ofir R, Seidman R, Rabinski T, et al. Taxol-induced apoptosis in human SKOV3 ovarian and MCF7 breast carcinoma cells is caspase-3 and caspase-9 independent. Cell Death Differ. 2002;9(6):636–642. .
   PubMed Web of Science ®Google Scholar
• Varbiro G, et al. Direct effect of Taxol on free radical formation and mitochondrial permeability transition. Free Radic Biol Med. 2001;31(4):548–558. .
   PubMed Web of Science ®Google Scholar
• Asghari F, Haghnavaz N, Shanehbandi D, et al. Differential altered expression of let-7a and miR-205 tumor-suppressor miRNAs in different subtypes of breast cancer under treatment with Taxol. Adv Clin Exp Med. 2018;27(7):941–945. .
   PubMed Web of Science ®Google Scholar
• Tao W-Y, Liang X-S, Liu Y, et al. Decrease of let-7f in low-dose metronomic Paclitaxel chemotherapy contributed to upregulation of thrombospondin-1 in breast cancer. Int J Biol Sci. 2015;11(1):48–58. .
   PubMed Web of Science ®Google Scholar
• Wanderley CW, Colón DF, Luiz JPM, et al. Paclitaxel reduces tumor growth by reprogramming tumor-associated macrophages to an M1 profile in a TLR4-dependent manner. Cancer Res. 2018;78(20):5891–5900. .
   PubMed Web of Science ®Google Scholar
• Panis C, Pavanelli WR. Cytokines as mediators of pain-related process in breast cancer. Mediators Inflamm. 2015;2015:129034.
   PubMed Web of Science ®Google Scholar
• Damaghi M, Wojtkowiak JW, Gillies RJ. pH sensing and regulation in cancer. Front Physiol. 2013;4:370.
   PubMed Web of Science ®Google Scholar
• Chiche J, Brahimi-Horn MC, Pouysségur J. Tumour hypoxia induces a metabolic shift causing acidosis: a common feature in cancer. J Cell Mol Med. 2010;14(4):771–794.
   PubMed Web of Science ®Google Scholar
• Grillo-Hill BK, Choi C, Jimenez-Vidal M, et al. Increased H⁺ efflux is sufficient to induce dysplasia and necessary for viability with oncogene expression. Elife. 2015;4. DOI:10.7554/eLife.03270.
   PubMed Web of Science ®Google Scholar
• Persi E, Duran-Frigola M, Damaghi M, et al. Systems analysis of intracellular pH vulnerabilities for cancer therapy. Nat Commun. 2018;9(1):2997. .
   PubMedGoogle Scholar
• Lauritzen G, Jensen MBF, Boedtkjer E, et al. NBCn1 and NHE1 expression and activity in DeltaNErbB2 receptor-expressing MCF-7 breast cancer cells: contributions to pHi regulation and chemotherapy resistance. Exp Cell Res. 2010;316(15):2538–2553. .
   PubMed Web of Science ®Google Scholar
• Wang B-Y, Zhang J, Wang J-L, et al. Intermittent high dose proton pump inhibitor enhances the antitumor effects of chemotherapy in metastatic breast cancer. J Exp Clin Cancer Res. 2015;34(1):85. .
   PubMedGoogle Scholar
• Amith SR, Wilkinson JM, Baksh S, et al. The Na⁺/H⁺ exchanger (NHE1) as a novel co-adjuvant target in paclitaxel therapy of triple-negative breast cancer cells. Oncotarget. 2015;6(2):1262–1275. .
   PubMedGoogle Scholar
• Fais S. Evidence-based support for the use of proton pump inhibitors in cancer therapy. J Transl Med. 2015;13:368.
   PubMed Web of Science ®Google Scholar
• Rebillard A, Tekpli X, Meurette O, et al. Cisplatin-induced apoptosis involves membrane fluidification via inhibition of NHE1 in human colon cancer cells. Cancer Res. 2007;67(16):7865–7874. .
   PubMed Web of Science ®Google Scholar
• He X, Wang Y, Wang K, et al. Research of the relationship of intracellular acidification and apoptosis in Hela cells based on pH nanosensors. Sci China Ser B Chem. 2007;50:258–265. .
   Google Scholar
• Marathe K, McVicar N, Li A, et al. Topiramate induces acute intracellular acidification in glioblastoma. J Neurooncol. 2016;130(3):465–472. .
   PubMed Web of Science ®Google Scholar
• Albatany M, Li A, Meakin S, et al. Dichloroacetate induced intracellular acidification in glioblastoma: in vivo detection using AACID-CEST MRI at 9.4 Tesla. J Neurooncol. 2018;136(2):255–262. .
   PubMed Web of Science ®Google Scholar
• Reshkin SJ, et al. Paclitaxel induces apoptosis via protein kinase A- and p38 mitogen-activated protein-dependent inhibition of the Na+/H+ exchanger (NHE) NHE isoform 1 in human breast cancer cells. Clin Cancer Res. 2003;9(6):2366–2373.
   PubMed Web of Science ®Google Scholar
• Matlashov ME, Bogdanova YA, Ermakova GV, et al. Fluorescent ratiometric pH indicator SypHer2: applications in neuroscience and regenerative biology. Biochim Biophys Acta. 2015;1850(11):2318–2328. .
   PubMed Web of Science ®Google Scholar
• Bizzarri R, Serresi M, Luin S, et al. Green fluorescent protein based pH indicators for in vivo use: a review. Anal Bioanal Chem. 2009;393(4):1107–1122. .
   PubMed Web of Science ®Google Scholar
• Benčina M. Illumination of the spatial order of intracellular pH by genetically encoded pH-sensitive sensors. Sensors (Basel). 2013;13(12):16736–16758.
   PubMed Web of Science ®Google Scholar
• Shirmanova MV, Druzhkova IN, Lukina MM, et al. Intracellular pH imaging in cancer cells in vitro and tumors in vivo using the new genetically encoded sensor SypHer2. Biochim Biophys Acta. 2015;1850(9):1905–1911. .
   PubMed Web of Science ®Google Scholar
• Druzhkova IN, Shirmanova MV, Lukina MM, et al. The metabolic interaction of cancer cells and fibroblasts – coupling between NAD(P)H and FAD, intracellular pH and hydrogen peroxide. Cell Cycle. 2016;15(9):1257–1266. .
   PubMed Web of Science ®Google Scholar
• Shrode LD, Tapper H, Grinstein S. Role of intracellular pH in proliferation, transformation, and apoptosis. J Bioenerg Biomembr. 1997;29(4):393–399.
   PubMed Web of Science ®Google Scholar
• Zagaynova EV, et al. Imaging of intracellular pH in tumor spheroids using genetically encoded sensor SypHer2. Adv Exp Med Biol. 2017;1035:105–119.
   PubMed Web of Science ®Google Scholar
• Vukovic V, Tannock IF. Influence of low pH on cytotoxicity of paclitaxel, mitoxantrone and topotecan. Br J Cancer. 1997;75(8):1167–1172.
   PubMed Web of Science ®Google Scholar
• Jia M, Zheng D, Wang X, et al. Cancer cell enters reversible quiescence through intracellular acidification to resist paclitaxel cytotoxicity. Int J Med Sci. 2020;17(11):1652–1664. .
   PubMed Web of Science ®Google Scholar
• Ehrlichova M, Vaclavikova R, Ojima I, et al. Transport and cytotoxicity of paclitaxel, docetaxel, and novel taxanes in human breast cancer cells. Naunyn Schmiedebergs Arch Pharmacol. 2005;372(1):95–105. .
   PubMed Web of Science ®Google Scholar
• Choi CH, Patel H, Barber DL. Expression of actin-interacting protein 1 suppresses impaired chemotaxis of Dictyostelium cells lacking the Na+-H+ exchanger NHE1. Mol Biol Cell. 2010;21(18):3162–3170.
   PubMed Web of Science ®Google Scholar
• Gottlieb RA, Nordberg J, Skowronski E, et al. Apoptosis induced in Jurkat cells by several agents is preceded by intracellular acidification. Proc Natl Acad Sci U S A. 1996;93(2):654–658. .
   PubMed Web of Science ®Google Scholar
• Liu FT, Newland AC, Jia L. Bax conformational change is a crucial step for PUMA-mediated apoptosis in human leukemia. Biochem Biophys Res Commun. 2003;310(3):956–962.
   PubMed Web of Science ®Google Scholar
• Matsuyama S, Llopis J, Deveraux QL, et al. Changes in intramitochondrial and cytosolic pH: early events that modulate caspase activation during apoptosis. Nat Cell Biol. 2000;2(6):318–325. .
   PubMed Web of Science ®Google Scholar
• Huizing MT, Misser VHS, Pieters RC, et al. Taxanes: a new class of antitumor agents. Cancer Invest. 1995;13(4):381–404. .
   PubMed Web of Science ®Google Scholar
• Lukina MM, Dudenkova VV, Ignatova NI, et al. Metabolic cofactors NAD(P)H and FAD as potential indicators of cancer cell response to chemotherapy with paclitaxel. Biochim Biophys Acta Gen Subj. 2018;1862(8):1693–1700. .
   PubMed Web of Science ®Google Scholar
• Svoboda M, Riha J, Wlcek K, et al. Organic anion transporting polypeptides (OATPs): regulation of expression and function. Curr Drug Metab. 2011;12(2):139–153. .
   PubMed Web of Science ®Google Scholar
• Leuthold S, Hagenbuch B, Mohebbi N, et al. Mechanisms of pH-gradient driven transport mediated by organic anion polypeptide transporters. Am J Physiol Cell Physiol. 2009;296(3):C570–82. .
   PubMed Web of Science ®Google Scholar
• Pan Z, Avila A, Gollahon L. Paclitaxel induces apoptosis in breast cancer cells through different calcium--regulating mechanisms depending on external calcium conditions. Int J Mol Sci. 2014;15(2):2672–2694.
   PubMed Web of Science ®Google Scholar
• Danthuluri NR, Kim D, Brock TA. Intracellular alkalinization leads to Ca2+ mobilization from agonist-sensitive pools in bovine aortic endothelial cells. J Biol Chem. 1990;265(31):19071–19076.
   PubMed Web of Science ®Google Scholar
• Li S, Hao B, Lu Y, et al. Li, S. Intracellular alkalinization induces cytosolic Ca2+ increases by inhibiting sarco/endoplasmic reticulum Ca2+-ATPase (SERCA). PLoS One. 2012;7(2):e31905. .
   PubMed Web of Science ®Google Scholar